0001739614-22-000124.txt : 20221118
0001739614-22-000124.hdr.sgml : 20221118
20221118170637
ACCESSION NUMBER: 0001739614-22-000124
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221117
FILED AS OF DATE: 20221118
DATE AS OF CHANGE: 20221118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lappe Mark
CENTRAL INDEX KEY: 0001366074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39452
FILM NUMBER: 221402719
MAIL ADDRESS:
STREET 1: 11622 EL CAMINO REAL
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lappe Family Trust
CENTRAL INDEX KEY: 0001821266
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39452
FILM NUMBER: 221402718
BUSINESS ADDRESS:
STREET 1: C/O INHIBRX, INC.
STREET 2: 11099 TORREY PINES ROAD, SUITE 280
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-759-1499
MAIL ADDRESS:
STREET 1: C/O INHIBRX, INC.
STREET 2: 11099 TORREY PINES ROAD, SUITE 280
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inhibrx, Inc.
CENTRAL INDEX KEY: 0001739614
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 824257312
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 795-4220
MAIL ADDRESS:
STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
wf-form4_166880918186617.xml
FORM 4
X0306
4
2022-11-17
0
0001739614
Inhibrx, Inc.
INBX
0001366074
Lappe Mark
C/O INHIBRX, INC.
11025 NORTH TORREY PINES ROAD, SUITE 200
LA JOLLA
CA
92037
1
1
0
0
Chief Executive Officer
0001821266
Lappe Family Trust
C/O INHIBRX, INC.
11025 NORTH TORREY PINES ROAD, SUITE 200
LA JOLLA
CA
92037
0
0
0
1
To be Verified
Common Stock
2022-11-17
4
S
0
6959
25.3596
D
2557293
I
By the Lappe Family Trust
Common Stock
2022-11-17
4
S
0
4106
26.5703
D
2553187
I
By the Lappe Family Trust
Common Stock
2022-11-17
4
S
0
4333
27.4492
D
2548854
I
By the Lappe Family Trust
Common Stock
2022-11-17
4
S
0
1767
28.8574
D
2547087
I
By the Lappe Family Trust
Common Stock
2022-11-17
4
S
0
6773
30.1485
D
2540314
I
By the Lappe Family Trust
Common Stock
2022-11-17
4
S
0
912
30.668
D
2539402
I
By the Lappe Family Trust
Common Stock
2022-11-17
4
S
0
1150
32.3837
D
2538252
I
By the Lappe Family Trust
Common Stock
500000
I
By trust
Common Stock
59462
I
The Mark Paul Lappe Roth IRA
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mark P. Lappe.
The shares were sold in multiple transactions at prices ranging from $25.00 to $25.985, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
These securities are directly owned by the Lappe Family Trust. Mark P. Lappe is a trustee of the Lappe Family Trust and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Lappe Family Trust.
The shares were sold in multiple transactions at prices ranging from $26.01 to $26.96, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were sold in multiple transactions at prices ranging from $27.04 to $28.00, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were sold in multiple transactions at prices ranging from $28.47 to $29.40, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were sold in multiple transactions at prices ranging from $29.47 to $30.31, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were sold in multiple transactions at prices ranging from $30.52 to $30.68, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were sold in multiple transactions at prices ranging from $31.97 to $32.75, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
These securities are directly owned by a trust, for the benefit of the reporting person's immediate family. Mark P. Lappe, as an immediate family member of the beneficiaries of the trust, may be deemed to indirectly beneficially own the securities owned by the trust.
/s/ Kelly D. Deck, attorney-in-fact
2022-11-18